Abstract
As the number of breast cancer survivors rises, interest in lifestyle modifications that can improve survival increases. The role of soy in breast cancer prevention has been studied and debated for years, and the role of soy’s bioactive compounds known as isoflavones continues to be a focus of research. This review summarizes the existing epidemiologic data evaluating the effect of dietary soy intake on breast cancer recurrence and mortality. While some concern exists regarding the pro-estrogenic effect of soy as a risk factor for disease relapse, the vast majority of data shows no increase in breast cancer recurrence and mortality with dietary soy intake.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
